| Heterogeneous Odds Ratio Estimation |
Jean Pauphilet |
London Business School |
PLCO |
Nov 4, 2020 |
PLCO-686 |
| Heterogeneous treatment effect estimation using instrumental variable in time-to-event data |
Uri Shalit |
Technion - Israel Institute of Technology |
HIPB |
May 13, 2024 |
HIPB-13 |
| HFHS Electronic Medical Records compared to HFHS PLCO data |
Melody Eide |
Henry Ford Health System |
PLCO |
Sep 9, 2014 |
PLCO-105 |
| Hispanic Recruitment for the PLCO Screening Trial |
Eduard Gamito |
University of Colorado |
PLCO |
Jul 1, 2006 |
2006-0249 |
| Histopathologic Image-based Deep Learning Classifier for Predicting Clinical Outcomes in Cancers |
Eunhyang Park |
Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea |
PLCO |
Sep 5, 2023 |
PLCOI-1315 |
| History of lethal prostate cancer in the screening arm of PLCO |
Jonathan Shoag |
NA |
PLCO |
Aug 7, 2015 |
PLCO-147 |
| History of Participants with Lung Cancer who Never Smoked |
William Hocking |
Marshfield Clinic |
PLCO |
Jul 1, 2006 |
2006-0192 |
| HMO Data Validation Pilot Study |
Paul Pinsky |
NCI, DCP, EDRG |
PLCO |
Jul 1, 2006 |
2006-0215 |
| Homologous recombination repair capacity and breast cancer risk: a nested case control study |
Hua Zhao |
Virginia Commonwealth University |
PLCO |
Oct 6, 2022 |
2021-1005 |
| Hormonal factors and risk of lung cancer: Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and a meta-analysis of 10 cohort studies |
Zuo-Feng Zhang |
Fielding School of Public Health, University of California, Los Angeles, CA, USA |
PLCO |
Oct 11, 2018 |
PLCO-406 |
| Hormonal factors and the risk of breast, endometrial, and ovarian cancers among nulliparous women |
Sara Schonfeld |
NCI, DCEG, REB |
PLCO |
Feb 15, 2008 |
2007-0064 |
| Hospital Mortality prediction |
Khoi Pham |
CSUSB |
NLST |
May 11, 2015 |
NLST-138 |
| How does vitamin E supplementation protect against clinically relevant prostate cancer in smokers? A molecular epidemiologic study in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screeni |
Demetrius Albanes |
NCI, DCEG, NEB |
PLCO |
May 7, 2007 |
2007-0007 |
| How effective is PSA Screening as a mode of prevention for Prostate Cancer in Men over the age of 50? |
Jiana Karthikeyan |
Franconian International School |
PLCO |
Apr 29, 2024 |
PLCO-1543 |
| HSD17B1 Genetics |
Richard Hayes |
NCI, DCEG, OEEB |
PLCO |
Jul 1, 2006 |
2006-0134 |
| HSQ Validation Study |
Lisa Gren |
University of Utah |
PLCO |
Jul 1, 2006 |
2006-0310 |
| Hyperinsulinemia and proinflammatory dietary pattern and the risk of esophageal cancers in the Prostate, Lung, Colon, and Ovary Prospective Study |
Ni Shi |
The Ohio State University |
PLCO |
Feb 6, 2025 |
PLCO-1809 |
| Identification and characterization of common genetic variants associated with circulating CA-125 |
Hannah Yang |
NCI, DCEG, HREB |
PLCO |
Jul 1, 2010 |
2010-0092 |
| Identification and Characterization of Genetic Variants Predisposing Cancer |
Jeffrey Smith |
Vanderbilt University Medical Center |
PLCO |
Feb 16, 2022 |
PLCO-918 |
| Identification and Quantification of Cardiac Calcium and cardiovascular Risk Stratification |
Ashish Gautam |
KardioLabs LLC |
NLST |
Mar 30, 2021 |
NLST-774 |
